These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 34690062)

  • 21. Impact of different dimethyl sulphoxide concentrations on cell recovery, viability and clonogenic potential of cryopreserved peripheral blood hematopoietic stem and progenitor cells.
    Smagur A; Mitrus I; Giebel S; Sadus-Wojciechowska M; Najda J; Kruzel T; Czerw T; Gliwinska J; Prokop M; Glowala-Kosinska M; Chwieduk A; Holowiecki J
    Vox Sang; 2013 Apr; 104(3):240-7. PubMed ID: 23046417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of the post-thaw CD34+ count with and without DMSO removal in the setting of autologous stem cell transplantation.
    Rohner N; Passweg JR; Tsakiris DA; Halter JP; Heim D; Buser AS; Infanti L; Holbro A
    Transfusion; 2019 Mar; 59(3):1052-1060. PubMed ID: 30556582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimizing a fully automated and closed system process for red blood cell reduction of human bone marrow products.
    Remley VA; Collins A; Underwood S; Jin J; Kim Y; Cai Y; Prochazkova M; Moses L; Byrne KM; Jin P; Stroncek DF; Highfill SL
    Cytotherapy; 2023 Apr; 25(4):442-450. PubMed ID: 36710226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Washing transplants with Sepax 2 reduces the incidence of side effects associated with autologous transplantation and increases patients' comfort.
    Huvarová L; Kořístek Z; Jelínek T; Černá L; Smejkalová J; Navrátil M; Grebeníček L; Tvrdá I; Michalíková M; Hájek R
    Transfusion; 2021 Aug; 61(8):2430-2438. PubMed ID: 34197635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased apoptosis in cryopreserved autologous hematopoietic progenitor cells collected by apheresis and delayed neutrophil recovery after transplantation: a nested case-control study.
    Wu L; Al-Hejazi A; Filion L; Ben R; Halpenny M; Yang L; Giulivi A; Allan DS
    Cytotherapy; 2012 Feb; 14(2):205-14. PubMed ID: 21954835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variable resistance to freezing and thawing of CD34-positive stem cells and lymphocyte subpopulations in leukapheresis products.
    Berens C; Heine A; Müller J; Held SA; Mayer K; Brossart P; Oldenburg J; Pötzsch B; Wolf D; Rühl H
    Cytotherapy; 2016 Oct; 18(10):1325-31. PubMed ID: 27491794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term storage at -80 degrees C of hematopoietic progenitor cells with 5-percent dimethyl sulfoxide as the sole cryoprotectant.
    Galmés A; Besalduch J; Bargay J; Novo A; Morey M; Guerra JM; Duran MA
    Transfusion; 1999 Jan; 39(1):70-3. PubMed ID: 9920169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantification of residual dimethylsulfoxide after washing cryopreserved stem cells and thawing tissue grafts.
    Decot V; Houzé P; Stoltz JF; Bensoussan D
    Biomed Mater Eng; 2009; 19(4-5):293-300. PubMed ID: 20042796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variable CD34+ recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemic.
    Purtill D; Antonenas V; Chiappini P; Tong D; O'Flaherty E; Bajel A; Kabani K; Larsen S; Tan S; Hutchins C; Curtis DJ; Kennedy GA; Watson AM; Bai L; Greenwood M; Gottlieb DJ; Hamad N
    Blood Adv; 2020 Sep; 4(17):4147-4150. PubMed ID: 32886750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydroxyethyl starch is an alternative washing solution for peripheral bloodstem cells products.
    Larrea L; Castro E; Vera B; Vayá MJ; Yagüe N; Mirabet V; Arbona C
    Transfus Apher Sci; 2021 Feb; 60(1):102915. PubMed ID: 32919883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of the relationship between CD34+ stem cell amount and DMSO in hematopoetic stem cell transplantation.
    Meriç N; Parmaksız A; Gülbaş Z
    Transpl Immunol; 2023 Jun; 78():101831. PubMed ID: 37019290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Manufacture of Autologous CD34
    Keever-Taylor CA; Heimfeld S; Steinmiller KC; Nash RA; Sullivan KM; Czarniecki CW; Granderson TC; Goldstein JS; Griffith LM
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1463-1472. PubMed ID: 28602891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viability and engraftment of hematopoietic progenitor cells after long-term cryopreservation: effect of diagnosis and percentage dimethyl sulfoxide concentration.
    Veeraputhiran M; Theus JW; Pesek G; Barlogie B; Cottler-Fox M
    Cytotherapy; 2010 Oct; 12(6):764-6. PubMed ID: 20353307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of lower concentrations of dimethyl sulfoxide on cryopreservation of autologous hematopoietic stem cells: a systematic review and meta-analysis of controlled clinical studies.
    Bennett B; Hanotaux J; Pasala AR; Hasan T; Hassan D; Shor R; Allan DS; Maganti HB
    Cytotherapy; 2024 May; 26(5):482-489. PubMed ID: 38416086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel method to evaluate prethawing viability of cryopreserved CD34+ hematopoietic stem cells for autologous transplantation.
    Marinelli Busilacchi E; Costantini A; Mancini G; Bencivenga R; Olivieri J; Battaglini G; Velletri L; Viola N; Butini L; Capelli D; Poloni A; Olivieri A
    Transfusion; 2020 Jul; 60(7):1529-1535. PubMed ID: 32488938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity.
    Reich-Slotky R; Colovai AI; Semidei-Pomales M; Patel N; Cairo M; Jhang J; Schwartz J
    Vox Sang; 2008 May; 94(4):351-7. PubMed ID: 18179677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of cryoprotectant exposure time on post-thaw viability of autologous and allogeneic hematopoietic stem cells and leukocyte subpopulations.
    Rimac V; Bojanić I; Dabelić S; Ćepulić BG
    Acta Pharm; 2023 Dec; 73(4):655-672. PubMed ID: 38147484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Processing of hematopoietic stem cells from peripheral blood before cryopreservation: use of a closed automated system.
    Zinno F; Landi F; Scerpa MC; Aureli V; Lanti A; Ceccarelli S; Caniglia M; Miele MJ; Daniele N; Landolfo A; Cometa AM; Locatelli F; Isacchi G
    Transfusion; 2011 Dec; 51(12):2656-63. PubMed ID: 21599671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of the recovery of cryopreserved and thawed CD34+ and CD3+ cells collected for hematopoietic transplantation.
    Fisher V; Khuu H; David-Ocampo V; Byrne K; Pavletic S; Bishop M; Fowler DH; Barrett AJ; Stroncek DF
    Transfusion; 2014 Apr; 54(4):1088-92. PubMed ID: 24117879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive value of the original content of CD34(+) cells for enrichment of hematopoietic progenitor cells from bone marrow harvests by the apheresis procedure.
    Itoh T; Minegishi M; Kudo Y; Saito N; Takahashi H; Suzuki A; Narita A; Sato Y; Miura J; Inoue Y; Kameoka J; Suwabe N; Imaizumi M; Okuda M; Tsuchiya S
    J Clin Apher; 2006 Oct; 21(3):176-80. PubMed ID: 16619225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.